← Evidence map

ArticleCureus2025

Sarcomatoid Lung Carcinoma Successfully Treated With Combined Cytotoxic Chemotherapy and Anti-Programmed Death-Ligand 1 (Anti-PD-L1) Antibodies.

Kohei Yoshimine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Sarcomatoid Lung Carcinoma Successfully Treated With Combined Cytotoxic Chemotherapy and Anti-Programmed Death-Ligand 1 (Anti-PD-L1) Antibodies. | OpenQuestion